ABSTRACT
AIM To analyze the increase in the cross-sectional area (CSA) of the median nerve during early childhood.
METHOD This prospective, cross-sectional study used high-resolution ultrasound images of the median nerve from three locations (wrist, forearm and upper arm). A total of 43 participants (32 of whom were children younger than 2 years) were included in the study.
RESULTS A strong and highly significant correlation was found between age and CSA (r = 0.8, p < 0.0001). The growth rate of CSA decreases with age. The increase in CSA follows a logarithmic growth curve (p < 0.0001). Based on the regression analysis, an age-synchronous increase in CSA for all three locations was found. The nerve reaches 70% of its final CSA by 2 years of age.
INTERPRETATION Similar to the nerve conduction speed, the increase in CSA is greatest during the first 2 years of life. Then, the rate gradually and synchronously slows at the proximal and distal locations.
What this paper adds
- Normative values for increased cross-sectional area (CSA) of the median nerve.
- Standardized locations and image procedures outlined for the clinical setting.
- Growth dynamic of the CSA of the median nerve in children.
- Normative data for development of the median nerve in children.
- High resolution ultrasound images of the maturating median nerve in neonates, infants and children.
Competing Interest Statement
This project was partly funded by Canon Medical Systems.
Clinical Trial
The study was approved by the local ethical committee and registered with the Swiss project database (RAPS, EKOS Nr. 19/166).
Funding Statement
This project was partly funded by Canon Medical Systems. Canon supplied the ultra sound imaging systems for the duration of the project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the local ethical committee and registered with the Swiss project database (RAPS, EKOS Nr. 19/166). Written informed consent was obtained from the caregivers prior to inclusion of participants in the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All measurement data is included in the submission.